NIH Guide to Grants and Contracts

The NIH Guide for Grants and Contracts is our official publication for NIH grant policies, guidelines and funding opportunities. We publish daily, and issue a table of contents weekly. Learn more about the NIH Guide and subscribe today!

The old advanced search is still avaliable.

New Features:

  • Tabular view - You can now view the search results in table format.
  • Export to excel - Search results can now be exported to excel for reporting purposes.

Results: 1 to 25 of 1228

Display Results as:

NIOSH Support for Conferences and Scientific Meetings (U13) - PAR-14-229

Organization: NIOSH 

Posting Date: 05-20-2014 

Expiration Date: 09-08-2019 

Activity Code: U13 

Summary: The purpose of the NIOSH Conference and Scientific Meeting Cooperative Program (U13) is to support high quality and impact scientific conferences/meetings that are relevant to NIOSHs scientific mission, program priorities, and to the public health. The conference cooperative agreement program is integral to the overall mission of NIOSH. An application should address and advance the field of occupational safety and health (http://www.cdc.gov/niosh/programs/ and http://www.cdc.gov/niosh/nora/default.html). A conference/scientific meeting is defined as a gathering, symposium, seminar, scientific meeting, workshop or any other organized and formal meeting where persons assemble or meet virtually to coordinate, exchange, and disseminate information or to explore or clarify a defined subject, problem, or area of knowledge. Applications for training-only events will not be considered under this announcement. For training opportunities, NIOSH recommends that an interested individual visit the NIOSH webpage for sponsored Education and Research Centers and Training Program Grants at http://www.cdc.gov/niosh/oep/default.html.  

NIOSH Support for Conferences and Scientific Meetings (R13) - PAR-14-246

Organization: NIOSH 

Posting Date: 06-03-2014 

Expiration Date: 09-08-2019 

Activity Code: R13 

Summary: The purpose of the NIOSH Conference Grant Program (R13) is to support high quality, investigator-initiated scientific conferences/meetings that are relevant to its scientific mission and to the public health. A conference/scientific meeting is defined as a gathering, symposium, seminar, scientific meeting, workshop or any other organized and formal meeting,whether conducted face-to-face or via the internet, where persons assemble or meet virtually to coordinate, exchange, and disseminate information or to explore or clarify a defined subject, problem, area of knowledge, or gaps in science, prevention/intervention or policies. 

AHRQ Small Research Grant Program (R03) - PA-15-147

Organization: AHRQ 

Posting Date: 03-19-2015 

Expiration Date: 07-17-2018 

Activity Code: R03 

Summary: This FOA encourages Small Research Grant (R03) applications, and expresses AHRQ priority areas of interest for ongoing small research projects. The R03 grant mechanism supports different types of health services research projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. 

Understanding and Improving Diagnostic Safety in Ambulatory Care: Strategies and Interventions (R18) - PA-15-179

Organization: AHRQ 

Posting Date: 04-08-2015 

Expiration Date: 09-27-2020 

Activity Code: R18 

Summary: Despite the growing interest and rapid pace of recent achievements, not much is known with a high degree of confidence about the strategies and interventions that might reduce diagnostic failures and patient harms or enhance the resilience and safety of diagnostic work. This Funding Opportunity Announcement (FOA) solicits applications from research institutions and their investigators to conduct Health Services Research Demonstration and Dissemination Projects (R18) to evaluate strategies and interventions for reducing diagnostic failures and patient harms, including approaches that enable organizations, providers and patients to better anticipate emerging diagnostic risk before failure and harm occurs.  

Understanding and Improving Diagnostic Safety in Ambulatory Care: Incidence and Contributing Factors (R01) - PA-15-180

Organization: AHRQ 

Posting Date: 04-08-2015 

Expiration Date: 11-06-2020 

Activity Code: R01 

Summary: Despite the growing interest and rapid pace of recent achievements, not much is known with a high degree of confidence about the prevalence of diagnostic failure in its various manifestations. This Funding Opportunity Announcement (FOA) solicits applications from research institutions and their investigators to conduct Health Services Research Projects (R01) to gain a better understanding of the complexity and incidence of diagnostic failure and its associated costs and harms. 

Summer Research Education Experience Programs (R25) - PAR-15-184

Organization: NIAAA 

Posting Date: 04-16-2015 

Expiration Date: 05-24-2018 

Activity Code: R25 

Summary: The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this R25 program is to support educational activities that foster a better understanding of biomedical, behavioral and clinical research and its implications. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Research Experiences for high school, undergraduate and science teachers during the summer academic break.  

Novel Tools and Devices for Animal Research Facilities and to Support the Care of Animal Models (R43/R44) - PAR-15-186

Organization: ORIP 

Posting Date: 04-16-2015 

Expiration Date: 09-06-2018 

Activity Code: R43/R44 

Summary: Research (SBIR) projects to develop novel tools and devices to improve handling of laboratory animals, to ease the management of animal facilities, and to enhance experiments which use animal models. The intent is to facilitate the development and implementation of tools and devices to directly benefit the welfare of research animals, and to advance equipment to improve infrastructure and environmental conditions of animal facilities that support biomedical and bio-behavioral research.  

Development of Novel Tools and Devices to Support the Care of Animal Models and Animal Care Research Facilities (R41/R42) - PAR-15-185

Organization: ORIP 

Posting Date: 04-16-2015 

Expiration Date: 09-06-2018 

Activity Code: R41/R42 

Summary: This funding opportunity announcement (FOA) encourages applications from small business concerns (SBCs) for Small Business Technology Transfer (STTR) projects to develop novel tools and devices to improve handling of laboratory animals, to ease the management of animal facilities, and to enhance experiments which use animal models. The intent is to facilitate the development and implementation of tools and devices to directly benefit the welfare of research animals, and to advance equipment to improve infrastructure and environmental conditions of animal facilities that support biomedical and bio-behavioral research.  

Enhancing Regulatory Science for the Risk Based Assessment of Emerging Manufacturing Technologies (U01) - PAR-15-187

Organization: FDA 

Posting Date: 04-17-2015 

Expiration Date: 05-01-2019 

Activity Code: U01 

Summary: The goal of this program is to support the advancement of regulatory science that can facilitate the implementation and the assessment of emerging manufacturing technology in the pharmaceutical sector. Emerging manufacturing technology can be viewed as a technology that has the potential to modernize the pharmaceutical manufacturing body of knowledge to support more robust, predictable, and/or cost-effective processes and with which the FDA has limited review or inspection experiences, due to its relative novelty. Examples of such elements include an innovative or novel: (1) product manufacturing technology, such as the dosage form; (2) manufacturing process (e.g., design, scale-up, and/or commercial scale); and/or (3) testing technology.  

Immune System Plasticity in the Pathogenesis and Treatment of Complex Dental, Oral, and Craniofacial Diseases (R21) - PAR-15-193

Organization: NIDCR 

Posting Date: 04-28-2015 

Expiration Date: 09-08-2018 

Activity Code: R21 

Summary: The purpose of this Funding Opportunity Announcement (FOA) is to encourage research projects to elucidate the role of immune system plasticity in health and in the pathogenesis of dental, oral, and craniofacial diseases. The goal is to advance knowledge of the immunological basis of dental, oral, and craniofacial diseases, and to develop tools and technologies for precise modulation of the immune system to restore or maintain health. The expectation is that new knowledge derived from this research will facilitate development of novel immunomodulatory therapies to prevent disease onset or reverse disease progression. 

Immune System Plasticity in the Pathogenesis and Treatment of Complex Dental, Oral, and Craniofacial Diseases (R01) - PAR-15-192

Organization: NIDCR 

Posting Date: 04-28-2015 

Expiration Date: 09-08-2018 

Activity Code: R01 

Summary: The purpose of this Funding Opportunity Announcement (FOA) is to encourage research projects to elucidate the role of immune system plasticity in health and in the pathogenesis of dental, oral, and craniofacial diseases. The goal is to advance knowledge of the immunological basis of dental, oral, and craniofacial diseases, and to develop tools and technologies for precise modulation of the immune system to restore or maintain health. The expectation is that new knowledge derived from this research will facilitate development of novel immunomodulatory therapies to prevent disease onset or reverse disease progression. 

Integrated Food Defense & Emergency Response Cooperative Agreement Program IFD&ER (U18) - RFA-FD-15-022

Organization: FDA 

Posting Date: 05-04-2015 

Expiration Date: 04-03-2019 

Activity Code: U18 

Summary: The Integrated Food Defense & Emergency Response Cooperative Agreement Program (IFD&ER CAP) grant awards are designed to generate food defense tools and resources that are easily replicated and can complement, aid in the development of, and/or improve State, local, Tribal and territorial (SLTT) food defense programs through unique, innovative, and reproducible projects . The known overlap between food safety (unintentional contamination) and food defense (intentional contamination) is extensive. And the pools of resources available are vast and sometimes difficult to locate and implement. As the Food Safety Modernization Act (FSMA) recognizes the evolution of the relationship between food safety and food defense, it is critical that these programs be integrated to the maximum extent possible in order to ensure the most efficient use of resources, as well as to optimize responses to incidents and events. 

Conference Grants to Advance Collaborative Research on Aging Biology (R13) - PAR-15-265

Organization: NIA 

Posting Date: 05-19-2015 

Expiration Date: 09-08-2018 

Activity Code: R13 

Summary: This Funding Opportunity Announcement (FOA) encourages the submission of conference grant applications in scientific areas that will foster extramural research on the molecular, biochemical, cellular, genetic, and physiological mechanisms underlying normal aging and related pathologies. NIA is particularly interested in promoting and facilitating team science by employing the R13 activity code to allow researchers at all levels of training to come together to exchange ideas, tools and approaches in an effort to increase collaborative research.  

Strategies to Increase Delivery of Guideline-Based Care to Populations with Health Disparities (R01) - PAR-15-279

Organization: NHLBI 

Posting Date: 06-18-2015 

Expiration Date: 06-22-2018 

Activity Code: R01 

Summary: This Funding Opportunity Announcement (FOA) invites applications to conduct innovative and feasible studies to test strategies to accelerate the adoption of guideline-based recommendations into clinical practice among populations with health disparities. Applications that propose strategies with a focus on providers who care for clinical populations with excess burden of cardiovascular, lung, blood, and sleep diseases and disorders, in concert with the health care delivery systems in which they practice, are strongly encouraged. Applications that test systems, infrastructures, and strategies to implement guideline-based care for NHLBI disorders in clinical care settings are also of high programmatic interest.  

Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01) - PAR-15-297

Organization: NCI 

Posting Date: 07-14-2015 

Expiration Date: 08-16-2018 

Activity Code: U01 

Summary: This Funding Opportunity Announcement (FOA) encourages the submission of applications that propose to advance research in cancer etiology and early detection biomarkers, utilizing the advantages of the unique biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial. The PLCO Biorepository offers high-quality, prospectively collected, serial pre-diagnostic blood samples from the PLCO screened arm participants, and a onetime collection of buccal cells from the control arm participants. Available data associated with the biospecimens includes demographic, diet, lifestyle, smoking, screening results, and clinical data. This FOA supports a wide range of cancer research including, but not limited to, biochemical and genetic analyses of cancer risk, as well as discovery and validation of early detection biomarkers. The proposed research project must involve use of PLCO biospecimens; additionally, it should also take advantage of the unique characteristics of the PLCO biospecimens. Research projects that do not involve the use of PLCO biospecimens will not be supported under this FOA. 

Establishing Outcome Measures for Clinical Studies of Oral and Craniofacial Diseases and Conditions (R21) - PAR-15-298

Organization: NIDCR 

Posting Date: 07-17-2015 

Expiration Date: 09-08-2018 

Activity Code: R21 

Summary: The goal of this funding opportunity announcement is to support the development of well-founded outcome measures, including establishing their reliability and validity, for clinical studies of those with oral and craniofacial diseases and conditions. 

Establishing Outcome Measures for Clinical Studies of Oral and Craniofacial Diseases and Conditions (R01) - PAR-15-302

Organization: NIDCR 

Posting Date: 07-17-2015 

Expiration Date: 09-08-2018 

Activity Code: R01 

Summary: The goal of this funding opportunity announcement is to support the development of well-founded outcome measures, including establishing their reliability and validity, for clinical studies of those with oral and craniofacial diseases and conditions. 

Occupational Safety and Health Education and Research Centers (T42) - PAR-15-303

Organization: CDC 

Posting Date: 07-21-2015 

Expiration Date: 10-21-2019 

Activity Code: T42 

Summary: The National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC), invites grant applications for funding Education and Research Centers (ERCs) that are focused on occupational safety and health training, research training, education and outreach. NIOSH is mandated to provide an adequate supply of qualified personnel to carry out the purposes of the Occupational Safety and Health Act, and the ERCs are one of the principal means for meeting this mandate. ERCs are academic institutions that provide high-quality interdisciplinary graduate training, research training, continuing education, and outreach in the core occupational safety and health disciplines of industrial hygiene (IH), occupational health nursing (OHN), occupational medicine residency (OMR), and occupational safety (OS), as well as closely related allied disciplines. Research and research training are integral components of ERCs, with ERC faculty and NIOSH trainees conducting research on issues related to the NIOSH National Occupational Research Agenda (NORA). The ERCs also serve as regional resources for industry, labor, government, and the public. 

Translational Studies on Adducts for Cancer Risk Identification and Prevention (U01) - PAR-15-307

Organization: NCI 

Posting Date: 07-24-2015 

Expiration Date: 07-12-2018 

Activity Code: U01 

Summary: This Funding Opportunity Announcement (FOA) encourages clinically-relevant translational/epidemiological research projects focused on the use of adducts to cellular macromolecules, as indicators of exposures to cancer risk factors in human populations and subgroups. The priority is on projects that will focus on adductomic approaches, i.e., address some aspects of the totality of adducts. The projects are expected to be based on comprehensive use of human biospecimens for which detailed medical data are available (e.g., biospecimens from the NCI-supported cohort studies). The main emphasis of this FOA is on advancing the area of cancer detection, cancer prevention, and assessing cancer risks in human populations and subgroups. Nonetheless, studies evaluating the potential roles of adducts in cancer etiology for gene-environment interaction research may also be appropriate provided that such projects are based on appropriate sets of human biospecimens (such as specimens from cohorts studies supported by NIH).  

Research to Advance Vaccine Safety (R01) - PA-15-312

Organization: NIAID 

Posting Date: 07-28-2015 

Expiration Date: 09-08-2018 

Activity Code: R01 

Summary: The purpose of this funding opportunity announcement (FOA) is to support research that will contribute to the overall understanding of vaccine safety. This research opportunity encourages studies that address scientific areas potentially relevant to vaccine safety such as 1) physiological and immunological responses to vaccines and vaccine components, 2) how genetic variations affect immune/physiological responses that may impact vaccine safety, 3) identification of risk factors and biological markers that may be used to assess whether there is a relationship between certain diseases or disorders and licensed vaccines, 4) creation/evaluation of statistical methodologies for analyzing data on vaccine safety, including data available from existing data sources such as passive reporting systems or healthcare databases, or 5) the application of genomic/molecular technologies and systems biology approaches to evaluate vaccine safety. This FOA aligns with the research goals and objectives outlined in the U.S. National Vaccine Plan). 

Research to Advance Vaccine Safety (R21) - PA-15-313

Organization: NIAID 

Posting Date: 07-28-2015 

Expiration Date: 09-08-2018 

Activity Code: R21 

Summary: The purpose of this funding opportunity announcement (FOA) is to support research that will contribute to the overall understanding of vaccine safety. This research opportunity encourages studies that address scientific areas potentially relevant to vaccine safety such as 1) physiological and immunological responses to vaccines and vaccine components, 2) how genetic variations affect immune/physiological responses that may impact vaccine safety, 3) identification of risk factors and biological markers that may be used to assess whether there is a relationship between certain diseases or disorders and licensed vaccines, 4) creation/evaluation of statistical methodologies for analyzing data on vaccine safety, including data available from existing data sources such as passive reporting systems or healthcare databases, or 5) the application of genomic/molecular technologies and systems biology approaches to evaluate vaccine safety. This FOA aligns with the research goals and objectives outlined in the U.S. National Vaccine Plan). 

Discovery of Genetic Basis of Monogenic Heart, Lung, Blood, and Sleep Disorders (X01) - PAR-15-314

Organization: NHLBI 

Posting Date: 07-29-2015 

Expiration Date: 06-16-2018 

Activity Code: X01 

Summary: This Funding Opportunity Announcement (FOA) invites applications to use the genome-wide sequencing capacity of the Centers for Mendelian Genomics to carry out studies of the genetic basis of Mendelian or monogenic disorders that significantly affect heart, lung, blood, and sleep (HLBS) systems. 

Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21) - PAR-15-334

Organization: NCI 

Posting Date: 08-18-2015 

Expiration Date: 11-21-2018 

Activity Code: R21 

Summary: The purpose of this Funding Opportunity Announcement (FOA) is to invite exploratory/developmental research grant (R21) applications for the development of innovative methods and algorithms in biomedical computing, informatics, and data science addressing priority needs across the cancer research continuum, including cancer biology, cancer treatment and diagnosis, cancer prevention, cancer control and epidemiology, and/or cancer health disparities.As a component of the NCI's Informatics Technology for Cancer Research (ITCR) Initiative, this FOA encourages applications focused on the development of novel computational, mathematical, and statistical algorithms and methods that can considerably improve acquisition, management, analysis, and dissemination of relevant data and/or knowledge. The central mission of ITCR is to promote research-driven informatics technology across the development lifecycle to address priority needs in cancer research. In order to be successful, the proposed informatics method or algorithm must have a clear rationale on why it is novel and how it will benefit the cancer research field. Potential applicants who are interested in more downstream tool development, from prototyping to hardening and adaptation, should consult the other companion FOAs listed above. 

Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01) - PAR-15-332

Organization: NCI 

Posting Date: 08-18-2015 

Expiration Date: 11-21-2018 

Activity Code: U01 

Summary: The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U01) applications for the development of enabling informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum including cancer biology, cancer treatment and diagnosis, cancer prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI's Informatics Technology for Cancer Research (ITCR) Program, this FOA focuses on early-stage development from prototyping to hardening and adaptation. Early-stage development is defined for the purpose of this FOA as the initial development or the significant modification of existing tools for new applications. The central mission of ITCR is to promote research-driven informatics technology across the development lifecycle to address priority needs in cancer research. In order to be successful, proposed development plans must have a clear rationale on why the proposed technology is needed and how it will benefit the cancer research field. In addition, mechanisms to solicit feedback from users and collaborators throughout the development process should be included.  

Advanced Development of Informatics Technologies for Cancer Research and Management (U24) - PAR-15-331

Organization: NCI 

Posting Date: 08-18-2015 

Expiration Date: 11-21-2018 

Activity Code: U24 

Summary: The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U24) applications for advanced development and enhancement of emerging informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum, including cancer biology, cancer treatment and diagnosis, cancer prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI's Informatics Technology for Cancer Research (ITCR) Initiative, this FOA focuses on emerging informatics technology, defined as one that has passed the initial prototyping and pilot development stage, has demonstrated potential to have a significant and broader impact, has compelling reasons for further improvement and enhancement, and has not been widely adopted in the cancer research field. The central mission of ITCR is to promote research-driven informatics technology across the development lifecycle to address priority needs in cancer research.In order to be successful, proposed development plans must have a clear rationale on why the proposed technology is needed and how it will benefit the cancer research field. In addition, mechanisms to solicit feedback from users and collaborators throughout the development process should be included. Potential applicants who are interested in early-stage development or informatics resource sustainment should consult companion FOAs listed above.  

Current Search

Refine Your Results

Program Announcements (PAs)

Parent Announcments Only

Requests for Applications (RFAs)

Issuing Only

All Organizations

AHRQ

CDC

DHHS

DOJ

EPA

FDA

FIC

HRSA

NASA

NCATS

NCBDDD

NCCDPHP

NCCIH

NCEH

NCHSTP

NCI

NCID

NCIPC

NCMHD

NCPHI

NCRR

NEI

NHGRI

NHLBI

NIA

NIAAA

NIAID

NIAMS

NIBIB

NICHD

NIDA

NIDCD

NIDCR

NIDDK

NIEHS

NIGMS

NIH

NIMH

NIMHD

NINDS

NINR

NIOSH

NIP

NLM

OAR

OBSSR

OD

ODP

ODS

OPHR

ORD

ORI

ORIP

ORWH

OSC

RMOD

Roadmap

SAMHSA

*On or After
*On or After
(e.g. "K" for K01 or K02, K05, etc.)
Back to Top